| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
9. Absence of mutation in p21 in breast witcers with wild-type p53
|
Evans, A.A.
|
|
1995
|
4 |
3 |
p. 229-
1 p.
|
artikel
|
| 2 |
102. Adjuvant tamoxifen duration in a randomized trial
|
Stewart, H.J.
|
|
1995
|
4 |
3 |
p. 256-
1 p.
|
artikel
|
| 3 |
22. A new model of human mammary epithelial apoptosis
|
Harris, R.A.
|
|
1995
|
4 |
3 |
p. 233-
1 p.
|
artikel
|
| 4 |
51. Angiogenesis in human breast carcinoma
|
Ellis, I.O.
|
|
1995
|
4 |
3 |
p. 241-242
2 p.
|
artikel
|
| 5 |
69. An open, comparative randomized trial comparing formestane vs oral megestrol acetate as second-line therapy in postmenopausal advanced breast cancer patients
|
Rose, C.
|
|
1995
|
4 |
3 |
p. 246-247
2 p.
|
artikel
|
| 6 |
2. A randomized, double-blind, multicentre crossover trial to evaluate in vivo inhibition of aromatase by Arimidex (ZD1033) (1 mg and 10 mg PO OD) in postmenopausal women with breast cancer
|
Geisler, J.
|
|
1995
|
4 |
3 |
p. 227-
1 p.
|
artikel
|
| 7 |
30. A randomized phase 11 evaluation of oral pamidronate for advanced bone metastases from breast cancer
|
Coleman, R.E.
|
|
1995
|
4 |
3 |
p. 235-236
2 p.
|
artikel
|
| 8 |
47. A randomized trial of concurrent tamoxifen (TAM) and cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM and delayed CEF after 6 months of endocrine therapy in metastatic breast cancer
|
Pfeiffer, P.
|
|
1995
|
4 |
3 |
p. 240-
1 p.
|
artikel
|
| 9 |
3. A randomized trial of the new specific aromatase inhibitor ‘Arimidex’ (anastrozole) versus megestrol acetate (MA) in the treatment of postmenopausal women with advanced breast cancer (ABC)
|
Jonat, W.
|
|
1995
|
4 |
3 |
p. 227-228
2 p.
|
artikel
|
| 10 |
1. Arimidex: profile of a potent, selective, orally active aromatase inhibitor
|
Dukes, M.
|
|
1995
|
4 |
3 |
p. 227-
1 p.
|
artikel
|
| 11 |
11. Association of 17q with 11q allele loss and with 5-year survival in human breast cancer.
|
Thompson, A.M.
|
|
1995
|
4 |
3 |
p. 230-
1 p.
|
artikel
|
| 12 |
Atlas of Breast Surgery
|
Dixon, J.M.
|
|
1995
|
4 |
3 |
p. 226-
1 p.
|
artikel
|
| 13 |
82. A unified approach to measurement of biomarkers in breast cancer
|
Leake, R.
|
|
1995
|
4 |
3 |
p. 250-251
2 p.
|
artikel
|
| 14 |
Axillary nodal irradiation in breast cancer: When and how?
|
Fourquet, A.
|
|
1995
|
4 |
3 |
p. 220-
1 p.
|
artikel
|
| 15 |
81. Axillary surgery can be avoided in selected breast cancer patients: analysis of 401 patients
|
Greco, M.
|
|
1995
|
4 |
3 |
p. 250-
1 p.
|
artikel
|
| 16 |
Bibliography of the breast
|
|
|
1995
|
4 |
3 |
p. B24-B37
nvt p.
|
artikel
|
| 17 |
76. Biological factors and response to primary radiotherapy in locally advanced breast cancer
|
Willsher, P.C.
|
|
1995
|
4 |
3 |
p. 248-249
2 p.
|
artikel
|
| 18 |
Breast cancer: a view from the frontline
|
Keswick, M.
|
|
1995
|
4 |
3 |
p. 205-210
6 p.
|
artikel
|
| 19 |
93. Breast cancer in the elderly patient — the case for clinical trials
|
Riley, D.
|
|
1995
|
4 |
3 |
p. 253-
1 p.
|
artikel
|
| 20 |
53. Breast cancer survival at 5 years is defined by pS2 expression and node status
|
Thompson, A.M.
|
|
1995
|
4 |
3 |
p. 242-
1 p.
|
artikel
|
| 21 |
91. Breast carcinomas in younger women are different
|
Walker, R.A.
|
|
1995
|
4 |
3 |
p. 253-
1 p.
|
artikel
|
| 22 |
95. Cancers detected by the breast screening programme in self referred women over the age of 65 years
|
Wilson, M.
|
|
1995
|
4 |
3 |
p. 254-
1 p.
|
artikel
|
| 23 |
66. Cardiac and vascular morbidity of tamoxifen
|
McDonald, C.C.
|
|
1995
|
4 |
3 |
p. 246-
1 p.
|
artikel
|
| 24 |
101. Change in expression of epidermal growth factor receptor and c-erb-B2 during the development of tamoxifen resistance in human breast cancer
|
Newby, J.C.
|
|
1995
|
4 |
3 |
p. 256-
1 p.
|
artikel
|
| 25 |
100. Changes in TGFB mRNA expression in breast cancer patients treated with tamoxifen
|
MacCallum, J.
|
|
1995
|
4 |
3 |
p. 255-256
2 p.
|
artikel
|
| 26 |
10. Chromosomal analysis of proliferative and malignant breast disease by chromosome in situ hybridization
|
Khoo, U.S.
|
|
1995
|
4 |
3 |
p. 230-
1 p.
|
artikel
|
| 27 |
21. Chronology and biology of breast cancer: the influence of screening
|
Anderson, T.J.
|
|
1995
|
4 |
3 |
p. 233-
1 p.
|
artikel
|
| 28 |
20. Clinical and radiological predictors of complete excision in breast conserving treatment
|
Gill, P.G.
|
|
1995
|
4 |
3 |
p. 233-
1 p.
|
artikel
|
| 29 |
Color Atlas of Breast Diseases
|
Dixon, J.M.
|
|
1995
|
4 |
3 |
p. 226-
1 p.
|
artikel
|
| 30 |
63. Comedo DCIS is hormone independent and will not benefit from antioestrogen therapy
|
Holland, P.
|
|
1995
|
4 |
3 |
p. 245-
1 p.
|
artikel
|
| 31 |
35. Comparability of prognostic indices
|
Howell, A.
|
|
1995
|
4 |
3 |
p. 237-
1 p.
|
artikel
|
| 32 |
97. Comparison of breast cancers in women with screen detected and symptomatic cancers
|
Gill, P.G.
|
|
1995
|
4 |
3 |
p. 254-255
2 p.
|
artikel
|
| 33 |
Conventional and new methods of imaging of axillary nodes in breast cancer
|
Ciatto, S.
|
|
1995
|
4 |
3 |
p. 222-223
2 p.
|
artikel
|
| 34 |
57. Detection of circulating tumour cells in patients with breast cancer using immunobead-PCR
|
Eaton, M.C.
|
|
1995
|
4 |
3 |
p. 243-
1 p.
|
artikel
|
| 35 |
23. Does parathyroid hormone related protein (PTHrP) cause microcalcification in breast cancer?
|
Walls, J.
|
|
1995
|
4 |
3 |
p. 233-
1 p.
|
artikel
|
| 36 |
58. Ductal carcinoma in situ — a 10-year review
|
Quinn, C.M.
|
|
1995
|
4 |
3 |
p. 243-244
2 p.
|
artikel
|
| 37 |
103. Duration of adjuvant tamoxifen therapy: preliminary results from the CRC trial
|
Baum, M.
|
|
1995
|
4 |
3 |
p. 256-
1 p.
|
artikel
|
| 38 |
31. Efficacy of pamidronate on skeletal complications from breast cancer metastases. A prospective randomized double-blind placebocontrolled trial
|
Hultbom, R.
|
|
1995
|
4 |
3 |
p. 236-
1 p.
|
artikel
|
| 39 |
Endometrial carcinoma associated with adjuvant tamoxifen therapy for breast cancer: a French multi-centre analysis of 89 cases
|
Mignotte, H.
|
|
1995
|
4 |
3 |
p. 200-202
3 p.
|
artikel
|
| 40 |
Entry into the tamoxifen prevention trial depends on women's estimates of the population risk of breast cancer
|
Thirlaway, K.
|
|
1995
|
4 |
3 |
p. 203-204
2 p.
|
artikel
|
| 41 |
29. Evaluation of new bone resorption markers in a comparison of pamidronate or clodronate for hypercalcaemia of malignancy
|
Vinholes, J.
|
|
1995
|
4 |
3 |
p. 235-
1 p.
|
artikel
|
| 42 |
43. Evidence for co-expression of p53 and c-myc in breast cancer
|
Thompson, A.M.
|
|
1995
|
4 |
3 |
p. 239-
1 p.
|
artikel
|
| 43 |
Fine needle aspiration cytology of breast carcinoma: a pre-operative prognostic tool?
|
Idvall, I.
|
|
1995
|
4 |
3 |
p. 189-195
7 p.
|
artikel
|
| 44 |
Fine needle aspiration cytology of the breast: improving the predictive value of equivocal cytologic reports by monoclonal antibody B72.3
|
Confortini, M.
|
|
1995
|
4 |
3 |
p. 172-174
3 p.
|
artikel
|
| 45 |
65. Fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen
|
Mouridsen, H.T.
|
|
1995
|
4 |
3 |
p. 245-246
2 p.
|
artikel
|
| 46 |
41. General practitioners providing breast cancer follow-up: results of a randomized trial
|
Grunfeld, E.
|
|
1995
|
4 |
3 |
p. 239-
1 p.
|
artikel
|
| 47 |
Handling of the surgical specimen
|
Zafrani, B.
|
|
1995
|
4 |
3 |
p. 215-216
2 p.
|
artikel
|
| 48 |
59. Histopathological parameters reflect the increased aggressiveness of comedo ductal carcinoma in situ
|
O'Hanlon, D.M.
|
|
1995
|
4 |
3 |
p. 244-
1 p.
|
artikel
|
| 49 |
4. Hormone therapy for advanced breast cancer; patients' perception
|
Leonard, R.C.F.
|
|
1995
|
4 |
3 |
p. 228-
1 p.
|
artikel
|
| 50 |
80. How safe is a watch policy in the management of axillary node disease with breast cancer?
|
Brooks, M.
|
|
1995
|
4 |
3 |
p. 250-
1 p.
|
artikel
|
| 51 |
32. Ibandronate: a well-tolerated new oral bisphosphonate for the treatment of bone metastases.
|
Coleman, R.E.
|
|
1995
|
4 |
3 |
p. 236-
1 p.
|
artikel
|
| 52 |
94. Immediate imaging of the breast after fine needle aspiration — is it safe?
|
Fenn, N.J.
|
|
1995
|
4 |
3 |
p. 254-
1 p.
|
artikel
|
| 53 |
Impact of radiotherapy on breast cosmesis
|
Kurtz, J.M.
|
|
1995
|
4 |
3 |
p. 163-169
7 p.
|
artikel
|
| 54 |
71. Infusional 5-fluorouracil (F) with epirubicin (E) and carboplatin (ECarboF) in advanced/metastatic breast cancer (ABC) — an outpatient regimen with less toxicity than ECF?
|
O'Brien, M.E.R.
|
|
1995
|
4 |
3 |
p. 247-
1 p.
|
artikel
|
| 55 |
Intra-operative staging of the axilla in operable breast cancer
|
Van Dongen, J.A.
|
|
1995
|
4 |
3 |
p. 216-217
2 p.
|
artikel
|
| 56 |
89. Invasive breast cancer in women aged < 35 years - the Nottingham experience
|
Kollias, J.
|
|
1995
|
4 |
3 |
p. 252-
1 p.
|
artikel
|
| 57 |
49. Is increased target organ sensitivity of the breast responsible for breast cancer development?
|
Harding, C.
|
|
1995
|
4 |
3 |
p. 241-
1 p.
|
artikel
|
| 58 |
70. Is there a place for magnetic resonance imaging (MRI) in breast cancer?
|
Davidson, T.
|
|
1995
|
4 |
3 |
p. 247-
1 p.
|
artikel
|
| 59 |
8. Localization of BRCA2 to chromosome 13Q12-13 by genetic linkage analysis
|
Wooster, R.
|
|
1995
|
4 |
3 |
p. 229-
1 p.
|
artikel
|
| 60 |
56. Long-term follow-up of breast cancer patients with micrometastatic tumour cells in bone marrow at primary surgery — prognostic impact in comparison to nodal status
|
Diel, I.J.
|
|
1995
|
4 |
3 |
p. 243-
1 p.
|
artikel
|
| 61 |
48. Long-term follow-up of neo-adjuvant therapy in operable breast cancer — an update of the original Edinburgh series
|
Cameron, D.A.
|
|
1995
|
4 |
3 |
p. 240-241
2 p.
|
artikel
|
| 62 |
28. Long-term review of breast cancer bone metastases
|
Walls, J.
|
|
1995
|
4 |
3 |
p. 235-
1 p.
|
artikel
|
| 63 |
Lymphoscintigraphy of the axilla with aspecific colloids and monoclonal antibodies
|
Th. Rutgers, E.J.
|
|
1995
|
4 |
3 |
p. 221-222
2 p.
|
artikel
|
| 64 |
98. Mammographic features of interval cancers and prognosis compared with screen detected and symptomatic breast cancers
|
Burrell, H.C.
|
|
1995
|
4 |
3 |
p. 255-
1 p.
|
artikel
|
| 65 |
92. Management of operable breast cancer in elderly patients (> 70 years)
|
Willsher, P.C.
|
|
1995
|
4 |
3 |
p. 253-
1 p.
|
artikel
|
| 66 |
Mondor's disease: is there any correlation with breast cancer?
|
Veronesi, P.
|
|
1995
|
4 |
3 |
p. 170-171
2 p.
|
artikel
|
| 67 |
62. Morphological and clinical characteristics in patients with ipsilateral recurrence after DCIS
|
Ringberg, A.
|
|
1995
|
4 |
3 |
p. 244-245
2 p.
|
artikel
|
| 68 |
75. Myeloablative therapy supported by peripheral blood stem cells (PBSC) in poor prognosis metastatic breast cancer — a phase 1/11 study
|
Cameron, D.A.
|
|
1995
|
4 |
3 |
p. 248-
1 p.
|
artikel
|
| 69 |
Node negative axillae: Should they be dissected?
|
Greco, M.
|
|
1995
|
4 |
3 |
p. 218-220
3 p.
|
artikel
|
| 70 |
88. Now or never? Breast reconstruction and psychological adjustment to breast cancer
|
Fallowfield, L.J.
|
|
1995
|
4 |
3 |
p. 252-
1 p.
|
artikel
|
| 71 |
61. Nuclear grade of DCIS does not predict for early local relapse
|
Holland, P.A.
|
|
1995
|
4 |
3 |
p. 244-
1 p.
|
artikel
|
| 72 |
84. Oestrogen receptor — a stable phenotype in breast cancer
|
Robertson, J.F.R.
|
|
1995
|
4 |
3 |
p. 251-
1 p.
|
artikel
|
| 73 |
83. Oestrogen receptor plays an important role in the expression of the oncogene C-erbB-2
|
Hubbard, A.L.
|
|
1995
|
4 |
3 |
p. 251-
1 p.
|
artikel
|
| 74 |
25. Oestrogen-regulated proteins and menstrual cycle in premenopausal breast cancer
|
Stonelake, P.S.
|
|
1995
|
4 |
3 |
p. 234-
1 p.
|
artikel
|
| 75 |
90. Operable breast cancer in women under 40 years of age
|
Luporsi, E.
|
|
1995
|
4 |
3 |
p. 253-
1 p.
|
artikel
|
| 76 |
77. Optimal loco-regional control in larger breast cancer with modified radical mastectomy and selective use of adjuvant radiotherapy
|
Rutgers, E.J.Th.
|
|
1995
|
4 |
3 |
p. 249-
1 p.
|
artikel
|
| 77 |
52. Parathyroid hormone receptor protein and its receptor expression in primary breast carcinomas — prognostic significance
|
Downey, S.E.
|
|
1995
|
4 |
3 |
p. 242-
1 p.
|
artikel
|
| 78 |
34. Pathological and immunohistochemical prognostic factors in clinically node-negative breast cancer patients receiving adjuvant tamoxifen (BR3002 trial)
|
Baker, P.R.
|
|
1995
|
4 |
3 |
p. 237-
1 p.
|
artikel
|
| 79 |
Patient-related factors influence treatment choice in operable breast cancer
|
Black, W.
|
|
1995
|
4 |
3 |
p. 196-199
4 p.
|
artikel
|
| 80 |
85. Pattern of expression of metastasis associated genes in breast cancer resected during various menstrual phases
|
Saad, Z.
|
|
1995
|
4 |
3 |
p. 251-
1 p.
|
artikel
|
| 81 |
14. p53 correlates strongly with tumour growth and expression of epidermal growth factor receptor (EGFR) in breast cancer
|
Stanton, P.D.
|
|
1995
|
4 |
3 |
p. 231-
1 p.
|
artikel
|
| 82 |
86. Pharmacokinetics, systemic and antitumour effects of the specific antioestrogen ICI 182780 in women with advanced breast cancer
|
DeFriend, D.J.
|
|
1995
|
4 |
3 |
p. 251-252
2 p.
|
artikel
|
| 83 |
15. Positive cavity biopsy does not predict early local relapse for patients treated by local excision for early breast cancer
|
van Dalen, R.
|
|
1995
|
4 |
3 |
p. 231-
1 p.
|
artikel
|
| 84 |
44. p53 overexpression in breast carcinoma: an expression of tumour dedifferentiation?
|
Khoo, U.S.
|
|
1995
|
4 |
3 |
p. 239-240
2 p.
|
artikel
|
| 85 |
40. Primary breast cancer in premenopausal women; where do patients receive optimum treatment?
|
Baildam, A.D.
|
|
1995
|
4 |
3 |
p. 238-239
2 p.
|
artikel
|
| 86 |
38. Primary chemotherapy and radiotherapy compared with primary radiotherapy alone in breast cancer stage IIb-IIIa
|
Semiglazov, V.F.
|
|
1995
|
4 |
3 |
p. 238-
1 p.
|
artikel
|
| 87 |
12. Prognostic indices in breast carcinoma from patients with an automsomal dominant family
|
Hosie, K.B.
|
|
1995
|
4 |
3 |
p. 230-
1 p.
|
artikel
|
| 88 |
Propensity of breast tumours to metastasize to regional nodes
|
Gusterson, B.
|
|
1995
|
4 |
3 |
p. 212-215
4 p.
|
artikel
|
| 89 |
73. Psychological correlates of breast cancer
|
Leinster, S.J.
|
|
1995
|
4 |
3 |
p. 248-
1 p.
|
artikel
|
| 90 |
99. Psychosocial implications of being ‘at risk’ of developing breast cancer
|
Thirlaway, K.
|
|
1995
|
4 |
3 |
p. 255-
1 p.
|
artikel
|
| 91 |
60. Radiotherapy may be unnecessary after adequate local excision of ductal carcinoma in situ
|
Sibbering, D.M.
|
|
1995
|
4 |
3 |
p. 244-
1 p.
|
artikel
|
| 92 |
104. Randomized phase III study of the new selective aromatase inhibitor arimidex (A) (ZD1033) versus megestrol acetate (MA) in the treatment of postmenopausal women with advanced breast cancer
|
Buzdar, A.U.
|
|
1995
|
4 |
3 |
p. 256-257
2 p.
|
artikel
|
| 93 |
68. Randomized trial between the selective aromatase inhibitor formestane (Lentaron) or tamoxifen as first-line hormonal therapy in postmenopausal patients with advanced breast cancer: confirmation of bioequivalence in survival
|
Royce, C.M.
|
|
1995
|
4 |
3 |
p. 246-
1 p.
|
artikel
|
| 94 |
36. Rates of local recurrence with neoadjuvant chemoendocrine therapy for primary breast cancer J. R. Benson, T. J. Powles, A. Makris, G. Knee,
|
Shley, J.
|
|
1995
|
4 |
3 |
p. 237-
1 p.
|
artikel
|
| 95 |
79. Regional recurrence in stage I and II breast cancer selection of patients at high risk for radiotherapy
|
Archer, S.G.
|
|
1995
|
4 |
3 |
p. 249-250
2 p.
|
artikel
|
| 96 |
18. Risk factors and survival of local recurrence (LR) as first site local relapse after treatment of invasive breast cancer (IBC)
|
Nielsen, M.
|
|
1995
|
4 |
3 |
p. 232-
1 p.
|
artikel
|
| 97 |
67. Risk of second malignancies following adjuvant chemo (CI) and tamoxifen (TMX) therapy
|
Boccardo, E.
|
|
1995
|
4 |
3 |
p. 246-
1 p.
|
artikel
|
| 98 |
17. Scottish trial of conservation therapy
|
Forrest, A.P.
|
|
1995
|
4 |
3 |
p. 232-
1 p.
|
artikel
|
| 99 |
Selecting patients for chemotherapy on the basis of tumour characteristics
|
Kaufmann, M.
|
|
1995
|
4 |
3 |
p. 220-221
2 p.
|
artikel
|
| 100 |
19. Selection criteria for breast conservation in primary operable invasive breast cancer
|
Sibbering, D.M.
|
|
1995
|
4 |
3 |
p. 232-233
2 p.
|
artikel
|
| 101 |
6. Single-agent paclitaxel in patients at first relapse following adjuvant chemotherapy for breast cancer
|
Davidson, N.G.
|
|
1995
|
4 |
3 |
p. 228-229
2 p.
|
artikel
|
| 102 |
33. Small breast cancer: an integrated index is still important
|
Murphy, C.A.
|
|
1995
|
4 |
3 |
p. 236-237
2 p.
|
artikel
|
| 103 |
26. Somatostatin receptor mRNA expression in normal and malignant breast tissue
|
Evans, A.A.
|
|
1995
|
4 |
3 |
p. 234-
1 p.
|
artikel
|
| 104 |
50. Standardizing the methodology of vessel density in breast cancer using immunohistochemistry and tumour microangiography
|
Martin, L.
|
|
1995
|
4 |
3 |
p. 241-
1 p.
|
artikel
|
| 105 |
78. Subcutaneous mastectomy for primary breast cancer or ductal carcinoma in situ
|
Cheung, K.L.
|
|
1995
|
4 |
3 |
p. 249-
1 p.
|
artikel
|
| 106 |
Surgical techniques: Full dissection of the axilla vs sampling in the treatment of operable breast cancer
|
Blichert-Toft, M.
|
|
1995
|
4 |
3 |
p. 217-218
2 p.
|
artikel
|
| 107 |
39. Surgical workload accounts for some of the variation in survival from breast cancer
|
Sainsbury, J.R.C.
|
|
1995
|
4 |
3 |
p. 238-
1 p.
|
artikel
|
| 108 |
55. Survival in lymph node positive breast cancer patients according to histological grade — possible evidence of cure
|
Kollias, J.
|
|
1995
|
4 |
3 |
p. 243-
1 p.
|
artikel
|
| 109 |
96. Survival of screen detected breast cancers
|
Anderson, E.D.C.
|
|
1995
|
4 |
3 |
p. 254-
1 p.
|
artikel
|
| 110 |
24. Synthesis and secretion of TGFb isoforms by breast tumour fibroblasts in vitro and modulation by tamoxifen
|
Benson, J.R.
|
|
1995
|
4 |
3 |
p. 233-234
2 p.
|
artikel
|
| 111 |
64. Tamoxifen does not promote tumour progression in surgically treated endometrial cancer
|
Kaufmann, M.
|
|
1995
|
4 |
3 |
p. 245-
1 p.
|
artikel
|
| 112 |
Tamoxifen: the need for a monitoring protocol
|
Oladipo, A.
|
|
1995
|
4 |
3 |
p. 224-225
2 p.
|
artikel
|
| 113 |
37. Tamoxifen therapy for stage III breast cancer: report on two randomized trials
|
Willsher, P.C.
|
|
1995
|
4 |
3 |
p. 238-
1 p.
|
artikel
|
| 114 |
54. The assessment of multiple variables on preoperative opeast carcinoma fine needle aspiration cytology specimens
|
Pinder, S.E.
|
|
1995
|
4 |
3 |
p. 242-243
2 p.
|
artikel
|
| 115 |
5. The combination of LHRH analogue and tamoxifen in premenopausal women with advanced breast cancer with skeletal metastases - updated results of a randomized study
|
Blarney, R.W.
|
|
1995
|
4 |
3 |
p. 228-
1 p.
|
artikel
|
| 116 |
42. The cost effectiveness of breast cancer follow-up
|
Murphy, C.A.
|
|
1995
|
4 |
3 |
p. 239-
1 p.
|
artikel
|
| 117 |
The extent and necessity of axillary dissection in breast cancer surgery
|
Baum, M.
|
|
1995
|
4 |
3 |
p. 211-212
2 p.
|
artikel
|
| 118 |
The feasibility of retrospective grading of breast cancer histology slides derived from multiple pathology services
|
Cummings, M.C.
|
|
1995
|
4 |
3 |
p. 179-182
4 p.
|
artikel
|
| 119 |
The identification of false negatives in a population of interval cancers: a method for audit of screening mammography
|
Simpson, W.
|
|
1995
|
4 |
3 |
p. 183-188
6 p.
|
artikel
|
| 120 |
13 The mammographic and pathological features of 1521 breast screening interval cancers
|
Wilson, A.R.M.
|
|
1995
|
4 |
3 |
p. 230-231
2 p.
|
artikel
|
| 121 |
27. The orthopaedic surgeon and breast cancer
|
O'Donoghue, D.S.
|
|
1995
|
4 |
3 |
p. 234-235
2 p.
|
artikel
|
| 122 |
74. The phospholipase D signal transduction pathway is up-regulated in multidrug resistant breast cancer cells
|
de Takats, P.G.
|
|
1995
|
4 |
3 |
p. 248-
1 p.
|
artikel
|
| 123 |
45. The psychological impact of recurrence of breast cancer
|
Falkson, A.
|
|
1995
|
4 |
3 |
p. 240-
1 p.
|
artikel
|
| 124 |
16. The role of radiotherapy in early breast cancer (stage I). A West Midlands Breast Group prospective randomized collaborative study (BR 3002).
|
Spooner, D.
|
|
1995
|
4 |
3 |
p. 231-232
2 p.
|
artikel
|
| 125 |
7. The yield of an intensive follow-up programme for women at increased risk for breast cancer
|
Rutgers, E.J.Th.
|
|
1995
|
4 |
3 |
p. 229-
1 p.
|
artikel
|
| 126 |
72. Thrombospondin and vascular endothelial growth factor expression in human breast cancer
|
Bowcott, M.
|
|
1995
|
4 |
3 |
p. 247-
1 p.
|
artikel
|
| 127 |
87. Thymidine kinase: a marker to measure tamoxifen response
|
O'Neill, K.L.
|
|
1995
|
4 |
3 |
p. 252-
1 p.
|
artikel
|
| 128 |
46. Understanding of prognosis on the psychological impact of recurrent breast cancer
|
Hall, A.
|
|
1995
|
4 |
3 |
p. 240-
1 p.
|
artikel
|
| 129 |
Vimentin and proliferating cell nuclear antigen (PCNA) expression in node-negative breast carcinomas and their correlations with pathologic variables and prognosis
|
Montesco, M.C.
|
|
1995
|
4 |
3 |
p. 175-178
4 p.
|
artikel
|
Tijdschrift beschrijving